397 related articles for article (PubMed ID: 25753158)
21. F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.
Sancho R; Jandke A; Davis H; Diefenbacher ME; Tomlinson I; Behrens A
Gastroenterology; 2010 Sep; 139(3):929-41. PubMed ID: 20638938
[TBL] [Abstract][Full Text] [Related]
22. Aberrant regulation of FBW7 in cancer.
Wang L; Ye X; Liu Y; Wei W; Wang Z
Oncotarget; 2014 Apr; 5(8):2000-15. PubMed ID: 24899581
[TBL] [Abstract][Full Text] [Related]
23. BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.
Keutgens A; Zhang X; Shostak K; Robert I; Olivier S; Vanderplasschen A; Chapelle JP; Viatour P; Merville MP; Bex F; Gothot A; Chariot A
J Biol Chem; 2010 Aug; 285(33):25831-40. PubMed ID: 20558726
[TBL] [Abstract][Full Text] [Related]
24. E3 ubiquitin ligase FBW7α inhibits cholangiocarcinoma cell proliferation by downregulating c-Myc and cyclin E.
Li M; Ouyang L; Zheng Z; Xiang D; Ti A; Li L; Dan Y; Yu C; Li W
Oncol Rep; 2017 Mar; 37(3):1627-1636. PubMed ID: 28184929
[TBL] [Abstract][Full Text] [Related]
25. FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation.
Tong J; Tan S; Zou F; Yu J; Zhang L
Oncogene; 2017 Feb; 36(6):787-796. PubMed ID: 27399335
[TBL] [Abstract][Full Text] [Related]
26. Fbxw7 acts as an E3 ubiquitin ligase that targets c-Myb for nemo-like kinase (NLK)-induced degradation.
Kanei-Ishii C; Nomura T; Takagi T; Watanabe N; Nakayama KI; Ishii S
J Biol Chem; 2008 Nov; 283(45):30540-8. PubMed ID: 18765672
[TBL] [Abstract][Full Text] [Related]
27. The two faces of FBW7 in cancer drug resistance.
Wang Z; Fukushima H; Gao D; Inuzuka H; Wan L; Lau AW; Liu P; Wei W
Bioessays; 2011 Nov; 33(11):851-9. PubMed ID: 22006825
[TBL] [Abstract][Full Text] [Related]
28. Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer.
Gao J; Azmi AS; Aboukameel A; Kauffman M; Shacham S; Abou-Samra AB; Mohammad RM
Oncotarget; 2014 Jun; 5(11):3444-54. PubMed ID: 24899509
[TBL] [Abstract][Full Text] [Related]
29. Fbw7 and its counteracting forces in stem cells and cancer: Oncoproteins in the balance.
Cremona CA; Sancho R; Diefenbacher ME; Behrens A
Semin Cancer Biol; 2016 Feb; 36():52-61. PubMed ID: 26410034
[TBL] [Abstract][Full Text] [Related]
30. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis.
Huang HL; Weng HY; Wang LQ; Yu CH; Huang QJ; Zhao PP; Wen JZ; Zhou H; Qu LH
Mol Cancer Ther; 2012 May; 11(5):1155-65. PubMed ID: 22389469
[TBL] [Abstract][Full Text] [Related]
31. MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression.
Lerner M; Lundgren J; Akhoondi S; Jahn A; Ng HF; Akbari Moqadam F; Oude Vrielink JA; Agami R; Den Boer ML; Grandér D; Sangfelt O
Cell Cycle; 2011 Jul; 10(13):2172-83. PubMed ID: 21597324
[TBL] [Abstract][Full Text] [Related]
32. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
Xu Y; Sengupta T; Kukreja L; Minella AC
J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
[TBL] [Abstract][Full Text] [Related]
34. The stomatin-like protein SLP-1 and Cdk2 interact with the F-Box protein Fbw7-γ.
Zhang W; MacDonald EM; Koepp DM
PLoS One; 2012; 7(10):e47736. PubMed ID: 23082202
[TBL] [Abstract][Full Text] [Related]
35. PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity.
Schülein C; Eilers M; Popov N
FEBS Lett; 2011 Jul; 585(14):2151-7. PubMed ID: 21620836
[TBL] [Abstract][Full Text] [Related]
36. Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development.
Tsunematsu R; Nakayama K; Oike Y; Nishiyama M; Ishida N; Hatakeyama S; Bessho Y; Kageyama R; Suda T; Nakayama KI
J Biol Chem; 2004 Mar; 279(10):9417-23. PubMed ID: 14672936
[TBL] [Abstract][Full Text] [Related]
37. SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.
Fukushima H; Matsumoto A; Inuzuka H; Zhai B; Lau AW; Wan L; Gao D; Shaik S; Yuan M; Gygi SP; Jimi E; Asara JM; Nakayama K; Nakayama KI; Wei W
Cell Rep; 2012 May; 1(5):434-43. PubMed ID: 22708077
[TBL] [Abstract][Full Text] [Related]
38. Mcl-1 ubiquitination and destruction.
Inuzuka H; Fukushima H; Shaik S; Liu P; Lau AW; Wei W
Oncotarget; 2011 Mar; 2(3):239-44. PubMed ID: 21608150
[TBL] [Abstract][Full Text] [Related]
39. Fbw7 dimerization determines the specificity and robustness of substrate degradation.
Welcker M; Larimore EA; Swanger J; Bengoechea-Alonso MT; Grim JE; Ericsson J; Zheng N; Clurman BE
Genes Dev; 2013 Dec; 27(23):2531-6. PubMed ID: 24298052
[TBL] [Abstract][Full Text] [Related]
40. Regulating Fbw7 on the road to cancer.
Xu W; Taranets L; Popov N
Semin Cancer Biol; 2016 Feb; 36():62-70. PubMed ID: 26459133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]